Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
Medtronic
McKinsey
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TELMISARTAN AND AMLODIPINE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Telmisartan And Amlodipine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00240474 A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study) Completed Boehringer Ingelheim Phase 4 2002-12-01 The primary objective of this study was test non-inferiority of telmisartan 80 mg + hydrochlorothiazide (HCTZ) 12.5 mg in comparison to amlodipine 10 mg + HCTZ 12.5 mg in reducing ambulatory systolic blood pressure (SBP) in the last 6 hours of the 24-hour dosing interval (determined by ambulatory blood pressure monitoring: ABPM) in elderly patients with predominantly systolic hypertension.
NCT00242814 Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities Completed Boehringer Ingelheim Phase 4 2005-10-01 The objective of the study is to compare PPAR activities (increase of adiponectin level) between MICARDIS and amlodipine after 6 weeks of treatment in hypertensive patients with metabolic syndrome. Moreover, this study will compare serum level of inflammatory markers of the metabolic syndrome after 6 weeks of treatment. An ancillary study performed in one center will assess adipocyte differentiation (PPAR gamma stimulation) in 30 subjects (15 per arm).
NCT00281580 Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension Completed Boehringer Ingelheim Phase 3 2006-04-01 To demonstrate that Micardis and Norvasc when used together are more effective at lowering blood pre ssure.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Telmisartan And Amlodipine

Condition Name

Condition Name for Telmisartan And Amlodipine
Intervention Trials
Hypertension 50
Healthy 15
Essential Hypertension 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Telmisartan And Amlodipine
Intervention Trials
Hypertension 42
Hyperlipidemias 9
Hyperlipoproteinemias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Telmisartan And Amlodipine

Trials by Country

Trials by Country for Telmisartan And Amlodipine
Location Trials
Korea, Republic of 60
United States 55
Japan 12
Canada 9
China 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Telmisartan And Amlodipine
Location Trials
California 3
Pennsylvania 3
Oklahoma 3
Georgia 3
Florida 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Telmisartan And Amlodipine

Clinical Trial Phase

Clinical Trial Phase for Telmisartan And Amlodipine
Clinical Trial Phase Trials
Phase 4 16
Phase 3 26
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Telmisartan And Amlodipine
Clinical Trial Phase Trials
Completed 65
Not yet recruiting 5
Recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Telmisartan And Amlodipine

Sponsor Name

Sponsor Name for Telmisartan And Amlodipine
Sponsor Trials
Boehringer Ingelheim 36
Chong Kun Dang Pharmaceutical 17
Yuhan Corporation 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Telmisartan And Amlodipine
Sponsor Trials
Industry 69
Other 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Merck
Johnson and Johnson
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.